THIS AWARD IS FOR THE DELIVERY OF A CGMP MANUFACTURED PRODUCT OF QUANTITY AND QUALITY THAT IT IS SUITABLE AND APPROPRIATE FOR USE IN PIVOTAL CLINICAL STUDIES TO DEMONSTRATE EFFICACY AGAINST ETEC IN ADULTS WITH THE GOAL OF FDA LICENSURE.
$12,425,876
| Recipient | SCANDINAVIAN BIOPHARMA HOLDING AB UEI ZKASUJ7ZZC98 |
|---|---|
| Award ID | W81XWH20C0137 |
| Award amount | $12,425,876 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Defense — Department of the Army |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | Q517 |
| Start date | Sep 25, 2020 |
| End date | Sep 25, 2023 |
| Place of performance | — |
| Record updated | May 5, 2022 |
View the official award record
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids